Combination Chemotherapy in Treating Patients With Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

2,005

Participants

Timeline

Start Date

September 30, 1997

Primary Completion Date

April 30, 2003

Study Completion Date

June 30, 2003

Conditions
Breast Cancer
Interventions
DRUG

cyclophosphamide

given IV

DRUG

doxorubicin hydrochloride

given IV

DRUG

paclitaxel

given IV

Trial Locations (19)

48106

CCOP - Ann Arbor Regional, Ann Arbor

55805

CCOP - Duluth, Duluth

55905

Mayo Clinic Cancer Center, Rochester

56303

CentraCare Clinic, Saint Cloud

57709

Rapid City Regional Hospital, Rapid City

58122

CCOP - Merit Care Hospital, Fargo

58201

Altru Health Systems, Grand Forks

58501

Quain & Ramstad Clinic, P.C., Bismarck

61602

CCOP - Illinois Oncology Research Association, Peoria

61801

CCOP - Carle Cancer Center, Urbana

68131

CCOP - Missouri Valley Cancer Consortium, Omaha

70121

CCOP - Ochsner, New Orleans

85259-5404

CCOP - Scottsdale Oncology Program, Scottsdale

52403-1206

CCOP - Cedar Rapids Oncology Project, Cedar Rapids

10309-1016

CCOP - Iowa Oncology Research Association, Des Moines

51101-1733

Siouxland Hematology-Oncology, Sioux City

43623-3456

CCOP - Toledo Community Hospital Oncology Program, Toledo

57105-1080

CCOP - Sioux Community Cancer Consortium, Sioux Falls

S4S 6X3

Saskatchewan Cancer Agency, Regina

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00003088 - Combination Chemotherapy in Treating Patients With Breast Cancer | Biotech Hunter | Biotech Hunter